康华生物 (300841.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(康华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,577,395,401.05990,055,021.87634,439,056.46278,114,028.881,446,724,761.501,054,548,588.74659,770,823.70266,736,074.86
 营业利润(元) 576,612,161.66408,526,287.21278,122,160.19117,037,987.62685,501,884.11550,937,598.24361,642,310.11156,134,499.12
 利润总额(元) 573,993,594.59408,031,286.23277,895,559.11116,889,024.59683,792,955.75549,874,937.62360,518,481.22156,134,338.16
 净利润(元) 509,215,964.75368,938,090.47248,204,882.62105,190,616.53598,066,216.17483,313,059.38315,676,487.23135,277,246.77
 归属于母公司股东的净利润(元) 509,215,964.75368,938,090.47248,204,882.62105,190,616.53598,066,216.17483,313,059.38315,676,487.23135,277,246.77
盈利能力:
 销售毛利率(%) 93.5293.5693.5293.5493.5693.6693.9294.19
 销售净利率(%) 32.2837.2639.1237.8241.3445.8347.8550.72
 净资产收益率(%) 15.4511.638.193.51----
 总资产报酬率ROA(%) 14.2911.047.813.36----
 投入资本回报率ROIC(%) 14.7010.917.443.2120.3116.7111.254.91
营运能力:
 存货周转率(次) 0.620.380.230.11----
 应收账款周转率(次) 1.170.780.520.25----
 总资产周转率(次) 0.400.270.180.08----
偿债能力:
 资产负债率(%) 16.5213.7014.3815.1717.1212.0212.779.61
 股东权益比率(%) 83.4886.3085.6284.8382.8887.9887.2390.39
 已获利息倍数(倍) -71.23-68.59-72.71-66.86-61.34-55.02-43.60-28.49
 流动比率 3.904.474.223.993.515.145.016.89
 速动比率 3.483.833.653.503.114.484.315.88
发展能力:
 营业收入增长率(%) 9.03-6.12-3.844.2711.9435.2319.5312.48
 营业利润增长率(%) -15.88-25.85-23.09-25.04-25.14-15.3621.0731.24
 税后利润增长率(%) -14.86-23.66-21.37-22.24-27.90-17.1525.1834.60
 净资产增长率(%) 14.2513.9916.2713.4515.1819.7130.8735.00
 总资产增长率(%) 13.4216.2018.4620.8922.9627.8537.9340.86

前瞻产业研究院